Receptor Life Sciences combines proven drug delivery technologies, compelling therapeutic candidates, and traditional drug development research practices to pursue a robust range of prescription drug treatments for CNS indications.

The delivery technologies, used in both oral and inhaled FDA-approved prescription drug products, represent a validated, strategic approach to overcoming traditional challenges of cannabinoid medicine.  Receptor’s patented product candidates hold the potential to provide prescription treatments for a range of unmet medical needs, including anxiety and agitation in autism.

More information is at www.ReceptorLife.com.

Biotechnology

Receptor Life Sciences, Inc.

Receptor Life Sciences, Inc.'s headquarters in Seattle, WA, United States

Description

People (1)

Gregory Wesner

Jobs